GelMA C combines nanofibrillated cellulose, which is jointly patented by UPM-Kymmene Corporation and CELLINK AB, with the advantages of GelMA. This blend offers smooth printability at room temperature without temperature control, and provides fibrillar morphology to benefit specific cell types. GelMA C crosslinks quickly through photocuring and with our ionic crosslinking solution. The ink retains its shear-thinning properties in physiological conditions and provides excellent printability at low extrusion pressures using a wide range of nozzle diameters. Available with LAP photoinitiator at 0.25 percent.
Recommended for use with BIO X, a temperature-controlled printhead and a cooled printbed, or INKREDIBLE+ with a heated printhead. Not recommended for use with INKREDIBLE.
$297.00 – $841.00
Available in a 3 mL cartridge.
Includes crosslinking agent.
Sterile production and packaging.
Four-month shelf life.
For research use only. Not for human use.
Product number: IK3511020303 (0.25% LAP 3 x 3 mL)
Product number: IK3511020305 (0.25% LAP 5 x 3 mL)
Product number: IK3511020310 (0.25% LAP 10 x 3 mL)
The bioink has the following quality criteria:
|Endotoxin level||<50 EU/mL|
|Cell viability||≥75% viable mesenchymal stem cells for 7 days|
|GelMA degree of methacrylation||45-55%|
|Viscosity||1-4 000 Pa·s|